General Information of Drug Off-Target (DOT) (ID: OTC08RWQ)

DOT Name Mpv17-like protein 2 (MPV17L2)
Gene Name MPV17L2
Related Disease
Multiple sclerosis ( )
UniProt ID
M17L2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF04117
Sequence
MARGGWRRLRRLLSAGQLLFQGRALLVTNTLGCGALMAAGDGVRQSWEIRARPGQVFDPR
RSASMFAVGCSMGPFLHYWYLSLDRLFPASGLRGFPNVLKKVLVDQLVASPLLGVWYFLG
LGCLEGQTVGESCQELREKFWEFYKADWCVWPAAQFVNFLFVPPQFRVTYINGLTLGWDT
YLSYLKYRSPVPLTPPGCVALDTRAD
Function Required for the assembly and stability of the mitochondrial ribosome. Is a positive regulator of mitochondrial protein synthesis.
KEGG Pathway
Peroxisome (hsa04146 )

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Multiple sclerosis DISB2WZI Strong Genetic Variation [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Mpv17-like protein 2 (MPV17L2). [2]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Mpv17-like protein 2 (MPV17L2). [3]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Mpv17-like protein 2 (MPV17L2). [4]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Mpv17-like protein 2 (MPV17L2). [5]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Mpv17-like protein 2 (MPV17L2). [6]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Mpv17-like protein 2 (MPV17L2). [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)

References

1 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251.
2 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
3 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
4 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
7 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.